• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COP 衣被蛋白复合体亚基β2(COPB2)基因上调靶向 NCI-H1975 肺腺癌细胞中的 microRNA-335-3p 促进细胞增殖和迁移。

Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.

机构信息

Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China (mainland).

Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital with Nanjing Medical University, Nanjing, Jiangsu, China (mainland).

出版信息

Med Sci Monit. 2020 Jan 31;26:e918382. doi: 10.12659/MSM.918382.

DOI:10.12659/MSM.918382
PMID:32004259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7006366/
Abstract

BACKGROUND The coatomer protein complex subunit beta 2 (COPB2) gene is upregulated and promotes cell proliferation in some cancer cells. This study aimed to investigate the role of microRNA (miRNA) targeting by COPB2 gene expression in human lung adenocarcinoma cell lines, including NCI-H1975 cells. MATERIAL AND METHODS COPB2 expression in normal human bronchial epithelial cells and lung adenocarcinoma cells was measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot. NCI-H1975 human lung adenocarcinoma cells were transfected with short-interfering COPB2 (siCOPB2). Cell apoptosis and cell proliferation were evaluated by flow cytometry and Cell Counting Kit-8 (CCK-8) assays, respectively. The transwell assay evaluated cell migration. Targeting of miR-335-3p by COPB2 was predicted using TargetScan 7.2 and verified using a dual-luciferase reporter assay in NCI-H1975 cells. MiR-335-3p mimics were transfected into NCI-H1975 cells. The further functional analysis included detection of protein expression for cyclin D1, tissue inhibitor matrix metalloproteinase-1 (TIMP-1), matrix metallopeptidase 9 (MMP9), Bcl-2, and Bax, to verify the role of miR-335-3p targeting by COPB2 in lung adenocarcinoma cells. RESULTS COPB2 was upregulated in lung adenocarcinoma cells and was a direct target of miR-335-3p mimics. COPB2 knockdown promoted cell apoptosis, inhibited cell migration and proliferation in NCI-H1975 cells. The effects of COPB2 knockdown on NCI-H1975 cells were increased by miR-335-3p mimics, which also further reduced the expression levels of cyclin D1, MMP9, and Bcl-2 and further increased TIMP-1 and Bax by siCOPB2. CONCLUSIONS This study showed that COPB2 was the functional target of miR-335-3p in NCI-H1975 human adenocarcinoma cells.

摘要

背景

衣被蛋白复合物亚基β 2(COPB2)基因在一些癌细胞中上调并促进细胞增殖。本研究旨在探讨 COPB2 基因表达通过 microRNA(miRNA)靶向在人肺腺癌细胞系中的作用,包括 NCI-H1975 细胞。

材料与方法

通过定量逆转录-聚合酶链反应(qRT-PCR)和 Western blot 测量正常人类支气管上皮细胞和肺腺癌细胞中的 COPB2 表达。用短发夹 RNA(siCOPB2)转染 NCI-H1975 人肺腺癌细胞。通过流式细胞术和细胞计数试剂盒-8(CCK-8)测定分别评估细胞凋亡和细胞增殖。Transwell 测定评估细胞迁移。使用 TargetScan 7.2 预测 COPB2 对 miR-335-3p 的靶向作用,并在 NCI-H1975 细胞中使用双荧光素酶报告基因测定进行验证。转染 miR-335-3p 模拟物进入 NCI-H1975 细胞。进一步的功能分析包括检测细胞周期蛋白 D1、组织抑制剂基质金属蛋白酶-1(TIMP-1)、基质金属肽酶 9(MMP9)、Bcl-2 和 Bax 的蛋白表达,以验证 COPB2 对肺腺癌细胞中 miR-335-3p 靶向作用的作用。

结果

COPB2 在肺腺癌细胞中上调,是 miR-335-3p 模拟物的直接靶标。COPB2 敲低促进 NCI-H1975 细胞的细胞凋亡,抑制细胞迁移和增殖。COPB2 敲低对 NCI-H1975 细胞的影响通过 miR-335-3p 模拟物增加,这进一步降低了细胞周期蛋白 D1、MMP9 和 Bcl-2 的表达水平,并进一步增加了 siCOPB2 的 TIMP-1 和 Bax。

结论

本研究表明,COPB2 是 NCI-H1975 人腺癌细胞中 miR-335-3p 的功能靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5b/7006366/952ac06a29fd/medscimonit-26-e918382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5b/7006366/86dd432af275/medscimonit-26-e918382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5b/7006366/429483636cc4/medscimonit-26-e918382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5b/7006366/952ac06a29fd/medscimonit-26-e918382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5b/7006366/86dd432af275/medscimonit-26-e918382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5b/7006366/429483636cc4/medscimonit-26-e918382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5b/7006366/952ac06a29fd/medscimonit-26-e918382-g003.jpg

相似文献

1
Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.COP 衣被蛋白复合体亚基β2(COPB2)基因上调靶向 NCI-H1975 肺腺癌细胞中的 microRNA-335-3p 促进细胞增殖和迁移。
Med Sci Monit. 2020 Jan 31;26:e918382. doi: 10.12659/MSM.918382.
2
MiR-216a-3p regulates the proliferation, apoptosis, migration, and invasion of lung cancer cells via targeting COPB2.miR-216a-3p 通过靶向 COPB2 调节肺癌细胞的增殖、凋亡、迁移和侵袭。
Biosci Biotechnol Biochem. 2020 Oct;84(10):2014-2027. doi: 10.1080/09168451.2020.1783197. Epub 2020 Jul 3.
3
MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).microRNA-140-3p 通过靶向 TYMS(胸苷酸合成酶)抑制肺腺癌细胞的增殖、迁移、侵袭和血管生成。
Bioengineered. 2021 Dec;12(2):11959-11977. doi: 10.1080/21655979.2021.2009422.
4
COPB2 promotes metastasis and inhibits apoptosis of lung adenocarcinoma cells through functioning as a target of miR-216a-3p.COPB2通过作为miR-216a-3p的靶标促进肺腺癌细胞的转移并抑制其凋亡。
Transl Cancer Res. 2020 Apr;9(4):2648-2659. doi: 10.21037/tcr.2020.02.65.
5
COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.COPB2 通过上调肺腺癌细胞中 YAP1 的表达促进细胞增殖和肿瘤发生。
Biomed Pharmacother. 2018 Jul;103:373-380. doi: 10.1016/j.biopha.2018.04.006. Epub 2018 Apr 24.
6
miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.miR-186-5p 通过靶向 PTEN 促进肺腺癌细胞的生长、迁移和侵袭。
Exp Mol Pathol. 2019 Jun;108:105-113. doi: 10.1016/j.yexmp.2019.04.007. Epub 2019 Apr 11.
7
MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.miR-552-3p 通过激活 ERK/GSK3β/β-catenin 信号通路海绵吸附 Fibulin 5 促进非小细胞肺癌细胞增殖、迁移和侵袭。
Tissue Cell. 2021 Dec;73:101672. doi: 10.1016/j.tice.2021.101672. Epub 2021 Oct 29.
8
MiR-200b-3p Functions as an Oncogene by Targeting ABCA1 in Lung Adenocarcinoma.miR-200b-3p 通过靶向 ABCA1 在肺腺癌中发挥癌基因作用。
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819892590. doi: 10.1177/1533033819892590.
9
MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma.miR-142-3p 通过抑制肺腺癌中的 NR2F6 抑制增殖、迁移和侵袭。
Hum Cell. 2019 Oct;32(4):437-446. doi: 10.1007/s13577-019-00258-0. Epub 2019 Jun 5.
10
MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.微小RNA-494-3p通过靶向Sox7促进鼻咽癌细胞的生长、迁移和侵袭。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809993. doi: 10.1177/1533033818809993.

引用本文的文献

1
MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).微小 RNA 在肺腺癌中的调控作用:信号通路与潜在治疗意义(综述)。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8648. Epub 2023 Oct 20.
2
LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis.长链非编码 RNA AP000695.2 通过 miR-335-3p/TEAD1 轴促进肺腺癌的糖酵解。
Acta Biochim Biophys Sin (Shanghai). 2023 Oct 25;55(10):1592-1605. doi: 10.3724/abbs.2023227.
3
Effects of on Histopathology, miRNA and mRNA Expression Dynamics in Lung of Goats.

本文引用的文献

1
miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin.miR-30e-5p 通过调控黏附连接蛋白抑制膀胱癌的细胞增殖和迁移。
J Cell Biochem. 2019 Sep;120(9):15924-15932. doi: 10.1002/jcb.28866. Epub 2019 May 8.
2
Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer.miR-4306 的转录下调可作为三阴性乳腺癌的新治疗靶点。
Theranostics. 2019 Feb 20;9(5):1401-1416. doi: 10.7150/thno.30701. eCollection 2019.
3
Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs.
[具体物质]对山羊肺部组织病理学、微小RNA(miRNA)和信使核糖核酸(mRNA)表达动态的影响
Animals (Basel). 2022 Jun 13;12(12):1529. doi: 10.3390/ani12121529.
4
Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis.COPB2表达在皮肤鳞状细胞癌发病机制中的意义。
Cancers (Basel). 2022 Apr 18;14(8):2038. doi: 10.3390/cancers14082038.
5
Chrysin Induced Cell Apoptosis Through /let-7a/ Axis in Gastric Cancer Cells and Inhibited Tumor Growth.白杨素通过/let-7a/轴诱导胃癌细胞凋亡并抑制肿瘤生长。
Front Oncol. 2021 Jun 3;11:651644. doi: 10.3389/fonc.2021.651644. eCollection 2021.
6
COPB2: a transport protein with multifaceted roles in cancer development and progression.COPB2:一种在癌症发展和进展中具有多方面作用的转运蛋白。
Clin Transl Oncol. 2021 Nov;23(11):2195-2205. doi: 10.1007/s12094-021-02630-9. Epub 2021 Jun 8.
基于微小RNA的结直肠癌原发肿瘤的新型分子特征分析
Cancers (Basel). 2019 Mar 11;11(3):346. doi: 10.3390/cancers11030346.
4
MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.微小 RNA 作为非小细胞肺癌转移治疗干预的潜在靶点。
Cancer Genomics Proteomics. 2019 Mar-Apr;16(2):99-119. doi: 10.21873/cgp.20116.
5
ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.ADAM17 选择性激活 KRAS 成瘾性肺癌中的 IL-6 转信号/ERK MAPK 轴。
EMBO Mol Med. 2019 Apr;11(4). doi: 10.15252/emmm.201809976.
6
Targeting ALK in Cancer: Therapeutic Potential of Proapoptotic Peptides.靶向癌症中的间变性淋巴瘤激酶(ALK):促凋亡肽的治疗潜力
Cancers (Basel). 2019 Feb 26;11(3):275. doi: 10.3390/cancers11030275.
7
MicroRNA in Lung Cancer Metastasis.微小RNA与肺癌转移
Cancers (Basel). 2019 Feb 23;11(2):265. doi: 10.3390/cancers11020265.
8
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.非小细胞肺癌伴脑转移患者接受检查点抑制剂治疗的结果。
J Thorac Oncol. 2019 Jul;14(7):1244-1254. doi: 10.1016/j.jtho.2019.02.009. Epub 2019 Feb 16.
9
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer.新型第三代 EGFR 酪氨酸激酶抑制剂及其克服肺癌治疗耐药的策略。
Cancer Res. 2019 Feb 15;79(4):689-698. doi: 10.1158/0008-5472.CAN-18-1281. Epub 2019 Feb 4.
10
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.